New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Anti-epidermal growth factor receptor therapy with the monoclonal antibodies cetuximab and panitumumab is the main targeted treatment to combine with standard chemotherapy for metastatic colorectal cancer. Many clinical studies have shown the benefit of the addition of these agents for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694794/
https://www.ncbi.nlm.nih.gov/pubmed/26318427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694794/
https://www.ncbi.nlm.nih.gov/pubmed/26318427

Ejemplares similares